Tarsus Share Price
NASDAQ: TARS | Mid Cap | HealthcareTarsus Stock Performance
Tarsus Share Price Today
As of 19 November 2026, Tarsus Pharmaceuticals, Inc.'s share price is $76.61. The stock opened at $78.27, compared to its previous close of $78.15. During today's trading session, Tarsus Pharmaceuticals, Inc.'s share price traded between $76.44 and $79.53, with an average price of $77.98. Over the past 52 weeks, the stock has recorded a high of $91.44 and a low of $54.18. In terms of performance, Tarsus Pharmaceuticals, Inc.'s share price has risen by 29.10% over the last six months and is down 4.49% on a year-on-year basis.
Tarsus Share Price Chart
Tarsus Quarterly Profit & Loss
All figures in USD
Tarsus Annual Profit & Loss
All figures in USD
Tarsus Balance Sheet
All figures in USD Million
Tarsus Cash Flow
All figures in USD Million
About Tarsus
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
Tarsus Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $75.50 | $76.52 | +2.35% |
Oct 2026 | $79.03 | $74.76 | -4.66% |
Sep 2026 | $74.11 | $78.42 | +8.99% |
Aug 2026 | $60.15 | $71.95 | +22.02% |
Jul 2026 | $65.04 | $58.97 | -6.18% |
Jun 2026 | $59.26 | $62.85 | +5.92% |
May 2026 | $62.60 | $59.34 | -6.84% |
Apr 2026 | $70.71 | $63.70 | -9.09% |
Mar 2026 | $74.11 | $70.07 | -7.20% |
Feb 2026 | $65.19 | $75.51 | +16.98% |
Jan 2026 | $81.56 | $64.55 | -21.29% |
Dec 2025 | $80.00 | $82.02 | +2.24% |